by Kelley Tracy | Oct 21, 2015 | Uncategorized
The Fox Chase Chemical Diversity Center Announces it has Registered it’s 5,000th FCCDC New Chemical Entity Since 2008 Doylestown, PA. October 21, 2015- FCCDC is pleased to announce that on Oct. 21, 2015 (Back to the Future Day!), the 5,000th FCCDC New...
by Kelley Tracy | Oct 6, 2015 | Uncategorized
The Fox Chase Chemical Diversity Center Announces a Research Collaboration with Portage Biotech Inc. and Biohaven Doylestown, PA. October 6, 2015- FCCDC is pleased to announce a research collaboration with Portage Biotech Inc. and Biohaven, as seen in...
by Kelley Tracy | May 20, 2015 | Uncategorized
The Fox Chase Chemical Diversity Center Announces it is Working Together With the Wistar Institute to Discover Inhibitors of Epstein Barr Nuclear Antigen EBNA1 for the Treatment of Epstein Barr Virus-Mediated Cancers Doylestown, PA. May 20, 2015- FCCDC is pleased...
by Kelley Tracy | May 11, 2015 | Uncategorized
The Fox Chase Chemical Diversity Center Announces that is Has Established a Strategic Partnership With the Prestigious Wistar Institute Doylestown, PA. May 11, 2015- The prestigious Wistar Institute (www.wistar.org) is the oldest independent nonprofit biomedical...
by Kelley Tracy | Mar 26, 2015 | Uncategorized
The Fox Chase Chemical Diversity Center Announces it Has Been Awarded a Phase I SBIR Grant Entitled “Pregnane X Receptor (PXR) Antagonists for Non-Alcoholic Fatty Liver Disease” Doylestown, PA. March 26, 2015- FCCDC is pleased to announce that it has been awarded...
